Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study.

Manson G, Maria ATJ, Poizeau F, Danlos FX, Kostine M, Brosseau S, Aspeslagh S, Du Rusquec P, Roger M, Pallix-Guyot M, Ruivard M, Dousset L, Grignou L, Psimaras D, Pluvy J, Quéré G, Grados F, Duval F, Bourdain F, Maigne G, Perrin J, Godbert B, Taifas BI, Forestier A, Voisin AL, Martin-Romano P, Baldini C, Marabelle A, Massard C, Honnorat J, Lambotte O, Michot JM.

J Immunother Cancer. 2019 Dec 3;7(1):337. doi: 10.1186/s40425-019-0821-8.

2.

Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: From pathogenesis to treatment.

Velasco R, Alberti P, Bruna J, Psimaras D, Argyriou AA.

J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S52-S62. doi: 10.1111/jns.12338. Review.

PMID:
31647153
3.

Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.

Staff NP, Cavaletti G, Islam B, Lustberg M, Psimaras D, Tamburin S.

J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S26-S39. doi: 10.1111/jns.12335. Review.

PMID:
31647151
4.

Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the Literature.

Pappa E, Berzero G, Herlin B, Ricard D, Tafani C, Devic P, Maillet D, Borden A, Viala K, Maisonobe T, Lenglet T, Weiss N, Psimaras D.

Oncologist. 2019 Oct 15. pii: theoncologist.2019-0255. doi: 10.1634/theoncologist.2019-0255. [Epub ahead of print]

PMID:
31615948
5.

Comparison of Lewis-Sumner syndrome with chronic inflammatory demyelinating polyradiculoneuropathy patients in a tertiary care centre.

Fargeot G, Maisonobe T, Psimaras D, Debs R, Lenglet T, Adams D, Vandendries C, Labeyrie C, Viala K.

Eur J Neurol. 2019 Oct 1. doi: 10.1111/ene.14101. [Epub ahead of print]

PMID:
31574194
6.

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.

Vogrig A, Fouret M, Joubert B, Picard G, Rogemond V, Pinto AL, Muñiz-Castrillo S, Roger M, Raimbourg J, Dayen C, Grignou L, Pallix-Guyot M, Lannoy J, Ducray F, Desestret V, Psimaras D, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2019 Aug 7;6(6). pii: e604. doi: 10.1212/NXI.0000000000000604. Print 2019 Nov.

7.

Immune checkpoint inhibitors-induced neuromuscular toxicity: From pathogenesis to treatment.

Psimaras D, Velasco R, Birzu C, Tamburin S, Lustberg M, Bruna J, Argyriou AA.

J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S74-S85. doi: 10.1111/jns.12339. Review.

PMID:
31393660
8.

Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings.

Argyriou AA, Park SB, Islam B, Tamburin S, Velasco R, Alberti P, Bruna J, Psimaras D, Cavaletti G, Cornblath DR; Toxic Neuropathy Consortium (TNC).

J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1361-1369. doi: 10.1136/jnnp-2019-320969. Epub 2019 Jun 29. Review.

PMID:
31256000
9.

Encephalitis induced by immune checkpoint inhibitors in metastatic melanoma: a monocentric retrospective study.

Galmiche S, Lheure C, Kramkimel N, Franck N, Boitier F, Dupin N, Turc G, Psimaras D, Aractingi S, Guégan S.

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e440-e443. doi: 10.1111/jdv.15756. Epub 2019 Jul 26. No abstract available.

PMID:
31219194
10.

CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS.

Taieb G, Mulero P, Psimaras D, van Oosten BW, Seebach JD, Marignier R, Pico F, Rigau V, Ueno Y, Duflos C, Fominykh V, Guiraud V, Lebrun-Frénay C, Camdessanché JP, Kerschen P, Ahle G, Téllez N, Rovira A, Hoang-Xuan K, Pelletier J, Labauge P; in cooperation with the French CLIPPERS group.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1027-1038. doi: 10.1136/jnnp-2018-318957. Epub 2019 May 9.

PMID:
31072955
11.

The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.

Chazal T, Costopoulos M, Maillart E, Fleury C, Psimaras D, Legendre P, Pineton de Chambrun M, Haroche J, Lubetzki C, Amoura Z, Legarff-Tavernier M, Cohen Aubart F.

Eur J Neurol. 2019 Oct;26(10):1274-1280. doi: 10.1111/ene.13975. Epub 2019 Jun 24.

PMID:
31021023
12.

Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis.

Chefdeville A, Treilleux I, Mayeur ME, Couillault C, Picard G, Bost C, Mokhtari K, Vasiljevic A, Meyronet D, Rogemond V, Psimaras D, Dubois B, Honnorat J, Desestret V.

Acta Neuropathol Commun. 2019 Mar 11;7(1):38. doi: 10.1186/s40478-019-0693-7.

13.

Balance Impairment in Radiation Induced Leukoencephalopathy Patients Is Coupled With Altered Visual Attention in Natural Tasks.

Bargiotas I, Moreau A, Vienne A, Bompaire F, Baruteau M, de Laage M, Campos M, Psimaras D, Vayatis N, Labourdette C, Vidal PP, Ricard D, Buffat S.

Front Neurol. 2019 Jan 23;9:1185. doi: 10.3389/fneur.2018.01185. eCollection 2018.

14.

Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma-a randomised multicentre trial (ASTER trial). An ANOCEF study.

Ursu R, Thomas L, Psimaras D, Chinot O, Le Rhun E, Ricard D, Charissoux M, Cuzzubbo S, Sejalon F, Quillien V, Hoang-Xuan K, Ducray F, Portal JJ, Tibi A, Mandonnet E, Levy-Piedbois C, Vicaut E, Carpentier AF.

Eur J Cancer. 2019 Mar;109:129-136. doi: 10.1016/j.ejca.2018.12.025. Epub 2019 Feb 1.

PMID:
30716716
15.

Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity.

Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E, Alberti P, Bruna J, Argyriou AA, Briani C, Velasco R, Kalofonos HP, Psimaras D, Ricard D, Pace A, Faber CG, Lalisang RI, Brandsma D, Koeppen S, Kerrigan S, Schenone A, Grisold W, Mazzeo A, Padua L, Dorsey SG, Penas-Prado M, Valsecchi MG; CI-PeriNomS Group.

J Peripher Nerv Syst. 2019 Mar;24(1):111-119. doi: 10.1111/jns.12306. Epub 2019 Feb 8.

PMID:
30672664
16.

Neuropathic pain, dysautonomia, and nerve hyperexcitability: Expanding the spectrum of LGI1 autoimmunity.

Berzero G, Lenglet T, Giry M, d'Anglejan J, Joubert B, Cohen F, Psimaras D.

Clin Neurophysiol. 2019 Feb;130(2):248-250. doi: 10.1016/j.clinph.2018.11.017. Epub 2018 Dec 7. No abstract available.

PMID:
30583271
17.

CNS inflammatory disorder after concurrent radiotherapy-temozolomide and nivolumab in a glioblastoma patient.

Di Stefano AL, Savatovsky J, Feuvret L, Villa C, Reina V, Pha M, Houillier C, Berzero G, Idbaih A, Psimaras D.

Neuro Oncol. 2019 Jan 1;21(1):139-141. doi: 10.1093/neuonc/noy168. No abstract available.

PMID:
30476174
18.

Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitis.

Maureille A, Fenouil T, Joubert B, Picard G, Rogemond V, Pinto AL, Thomas L, Ducray F, Quadrio I, Psimaras D, Berzero G, Antoine JC, Desestret V, Honnorat J.

J Neurol. 2019 Jan;266(1):195-206. doi: 10.1007/s00415-018-9132-0. Epub 2018 Nov 20.

PMID:
30460450
19.

Neuromuscular complications of immune checkpoint inhibitors.

Psimaras D.

Presse Med. 2018 Nov - Dec;47(11-12 Pt 2):e253-e259. doi: 10.1016/j.lpm.2018.10.009. Epub 2018 Nov 6. Review.

PMID:
30413332
20.

Neurological paraneoplastic syndromes: an update.

Berzero G, Psimaras D.

Curr Opin Oncol. 2018 Nov;30(6):359-367. doi: 10.1097/CCO.0000000000000479. Review.

PMID:
30124520
21.

Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosis.

Jachiet V, Lhote R, Rufat P, Pha M, Haroche J, Crozier S, Dupel-Potier C, Psimaras D, Amoura Z, Cohen Aubart F.

J Neurol. 2018 Oct;265(10):2333-2341. doi: 10.1007/s00415-018-9001-x. Epub 2018 Aug 14.

22.

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer.

Touat M, Maisonobe T, Knauss S, Ben Hadj Salem O, Hervier B, Auré K, Szwebel TA, Kramkimel N, Lethrosne C, Bruch JF, Laly P, Cadranel J, Weiss N, Béhin A, Allenbach Y, Benveniste O, Lenglet T, Psimaras D, Stenzel W, Léonard-Louis S.

Neurology. 2018 Sep 4;91(10):e985-e994. doi: 10.1212/WNL.0000000000006124. Epub 2018 Aug 8. Erratum in: Neurology. 2019 Aug 6;93(6):280.

PMID:
30089619
23.

Cognitive impairment and morphological changes after radiation therapy in brain tumors: A review.

Jacob J, Durand T, Feuvret L, Mazeron JJ, Delattre JY, Hoang-Xuan K, Psimaras D, Douzane H, Ribeiro M, Capelle L, Carpentier A, Ricard D, Maingon P.

Radiother Oncol. 2018 Aug;128(2):221-228. doi: 10.1016/j.radonc.2018.05.027. Epub 2018 Jul 2. Review.

PMID:
30041961
24.

Subacute inflammatory demyelinating polyradiculoneuropathy complicating relapsing Hodgkin lymphoma: another immune-related adverse event of the anti-PD1 therapy?

Barp A, Gilardin L, Afanasiev V, Delorme C, Viala K, Bernard S, Brice P, Psimaras D, Lenglet T.

Leuk Lymphoma. 2019 Feb;60(2):547-549. doi: 10.1080/10428194.2018.1485912. Epub 2018 Jul 22. No abstract available.

PMID:
30033838
25.

Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.

Bost C, Chanson E, Picard G, Meyronet D, Mayeur ME, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Desestret V, Honnorat J.

J Neurol. 2018 Oct;265(10):2190-2200. doi: 10.1007/s00415-018-8970-0. Epub 2018 Jul 12.

PMID:
30003358
26.

New insights in radiation-induced leukoencephalopathy: a prospective cross-sectional study.

Bompaire F, Lahutte M, Buffat S, Soussain C, Ardisson AE, Terziev R, Sallansonnet-Froment M, De Greslan T, Edmond S, Saad M, Nioche C, Durand T, Alamowitch S, Xuan KH, Delattre JY, Renard JL, Taillia H, Chargari C, Psimaras D, Ricard D.

Support Care Cancer. 2018 Dec;26(12):4217-4226. doi: 10.1007/s00520-018-4296-9. Epub 2018 Jul 7.

PMID:
29982900
27.

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.

Vialatte de Pémille C, Berzero G, Small M, Psimaras D, Giry M, Daniau M, Sanson M, Delattre JY, Honnorat J, Desestret V, Alentorn A.

Br J Cancer. 2018 Jul;119(1):105-113. doi: 10.1038/s41416-018-0125-7. Epub 2018 Jun 14.

28.

An anti-NMDA receptor encephalitis mimicking an HIV encephalitis.

Haneche F, Demeret S, Psimaras D, Katlama C, Pourcher V.

Clin Immunol. 2018 Aug;193:10-11. doi: 10.1016/j.clim.2018.05.003. Epub 2018 May 14.

PMID:
29772276
29.

Motor neuron disease of paraneoplastic origin: a rare but treatable condition.

Mélé N, Berzero G, Maisonobe T, Salachas F, Nicolas G, Weiss N, Beaudonnet G, Ducray F, Psimaras D, Lenglet T.

J Neurol. 2018 Jul;265(7):1590-1599. doi: 10.1007/s00415-018-8881-0. Epub 2018 May 3. Review.

PMID:
29725842
30.

Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy.

Lecler A, Charbonneau F, Psimaras D, Metten MA, Gueguen A, Hoang Xuan K, Feuvret L, Savatovsky J.

Eur Radiol. 2018 Oct;28(10):4324-4333. doi: 10.1007/s00330-018-5356-8. Epub 2018 Apr 12.

PMID:
29651771
31.

CLIPPERS mimickers: relapsing brainstem encephalitis associated with anti-MOG antibodies.

Berzero G, Taieb G, Marignier R, Younan N, Savatovsky J, Leclercq D, Psimaras D.

Eur J Neurol. 2018 Feb;25(2):e16-e17. doi: 10.1111/ene.13483. No abstract available.

PMID:
29356261
32.

Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis.

Favier M, Joubert B, Picard G, Rogemond V, Thomas L, Rheims S, Bailhache M, Villega F, Pédespan JM, Berzero G, Psimaras D, Antoine JC, Desestret V, Honnorat J.

Eur J Paediatr Neurol. 2018 May;22(3):404-411. doi: 10.1016/j.ejpn.2017.12.014. Epub 2017 Dec 28.

PMID:
29310866
33.

Episodic Memory Impairments in Primary Brain Tumor Patients.

Durand T, Berzero G, Bompaire F, Hoffmann S, Léger I, Jego V, Baruteau M, Delgadillo D, Taillia H, Psimaras D, Ricard D.

Arch Clin Neuropsychol. 2018 Dec 1;33(8):949-955. doi: 10.1093/arclin/acx138.

PMID:
29309500
34.

Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

Small M, Treilleux I, Couillault C, Pissaloux D, Picard G, Paindavoine S, Attignon V, Wang Q, Rogemond V, Lay S, Ray-Coquard I, Pfisterer J, Joly F, Du Bois A, Psimaras D, Bendriss-Vermare N, Caux C, Dubois B, Honnorat J, Desestret V.

Acta Neuropathol. 2018 Apr;135(4):569-579. doi: 10.1007/s00401-017-1802-y. Epub 2018 Jan 3.

PMID:
29299667
35.

Antineoplastic agents exacerbating Charcot Marie Tooth disease: red flags to avoid permanent disability.

Ibañez-Juliá MJ, Berzero G, Reyes-Botero G, Maisonobe T, Lenglet T, Slim M, Louis S, Balaguer A, Sanson M, Le Guern E, Latour P, Ricard D, Stojkovic T, Psimaras D.

Acta Oncol. 2018 Mar;57(3):403-411. doi: 10.1080/0284186X.2017.1415462. Epub 2017 Dec 15.

PMID:
29243538
36.

Brain volumetric analysis and cortical thickness in adults with saccadic intrusions (ocular flutter or opsoclonus-myoclonus syndrome).

Ibáñez-Juliá MJ, Pappa E, Gaymard B, Leclercq D, Hautefort C, Tilikete C, Delattre JY, Hoang-Xuan K, Psimaras D, Alentorn A.

Clin Neurol Neurosurg. 2017 Dec;163:167-172. doi: 10.1016/j.clineuro.2017.10.028. Epub 2017 Oct 31.

PMID:
29121544
37.

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies.

Berzero G, Karantoni E, Dehais C, Ducray F, Thomas L, Picard G, Rogemond V, Candelier G, Camdessanché JP, Antoine JC, De Seze J, Liou-Schischmanoff A, Honnorat J, Delattre JY, Psimaras D.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):789-792. doi: 10.1136/jnnp-2017-316904. Epub 2017 Oct 30. No abstract available.

38.

Neurological toxicities associated with immune-checkpoint inhibitors.

Touat M, Talmasov D, Ricard D, Psimaras D.

Curr Opin Neurol. 2017 Dec;30(6):659-668. doi: 10.1097/WCO.0000000000000503. Review.

PMID:
28938341
39.

Cerebral pseudo-tumoral neuro-Behcet: Histological demonstration of an inflammatory and vascular disease.

Cohen-Aubart F, Psimaras D, Galanaud D, Bielle F, Touitou V, Haroche J, Amoura Z.

Clin Neurol Neurosurg. 2017 Oct;161:48-50. doi: 10.1016/j.clineuro.2017.08.004. Epub 2017 Aug 12. No abstract available.

PMID:
28843707
40.

Safety of treatment with nivolumab after ipilimumab-related meningoradiculitis and bilateral optic neuropathy.

Boisseau W, Touat M, Berzero G, Savatovsky J, Marabelle A, Touitou V, Ricard D, Malouf G, Psimaras D.

Eur J Cancer. 2017 Sep;83:28-31. doi: 10.1016/j.ejca.2017.05.036. Epub 2017 Jul 12. No abstract available.

PMID:
28710954
41.

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis.

Joubert B, Gobert F, Thomas L, Saint-Martin M, Desestret V, Convers P, Rogemond V, Picard G, Ducray F, Psimaras D, Antoine JC, Delattre JY, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 14;4(4):e371. doi: 10.1212/NXI.0000000000000371. eCollection 2017 Jul.

42.

Capecitabine-induced acute toxic leukoencephalopathy.

Obadia M, Leclercq D, Wasserman J, Galanaud D, Dormont D, Sahli-Amor M, Psimaras D, Pyatigorskaya N, Law-Ye B.

Neurotoxicology. 2017 Sep;62:1-5. doi: 10.1016/j.neuro.2017.05.001. Epub 2017 May 6.

PMID:
28487252
43.

Human Herpesvirus 6 (HHV-6) necrotizing encephalitis, a rare condition in immunocompromised patients: The importance of brain biopsy associated with HHV-6 testing.

Le Guennec L, Mokhtari K, Chauvet D, Dupuis N, Roos-Weil D, Agut H, Leclercq D, Psimaras D, Mayaux J, Demeret S, Choquet S, Auvin S, Bonnafous P, Gautheret-Dejean A, Weiss N.

J Neurol Sci. 2017 Jun 15;377:112-115. doi: 10.1016/j.jns.2017.04.003. Epub 2017 Apr 6. No abstract available.

PMID:
28477677
44.

Chemotherapy-related cognitive impairment or « chemobrain »: concept and state of art.

Bompaire F, Durand T, Léger-Hardy I, Psimaras D, Ricard D.

Geriatr Psychol Neuropsychiatr Vieil. 2017 Mar 1;15(1):89-98. doi: 10.1684/pnv.2017.0659. Review.

PMID:
28266346
45.

Long-term outcomes of refractory neurosarcoidosis treated with infliximab.

Cohen Aubart F, Bouvry D, Galanaud D, Dehais C, Mathey G, Psimaras D, Haroche J, Pottier C, Hie M, Mathian A, Devilliers H, Nunes H, Valeyre D, Amoura Z.

J Neurol. 2017 May;264(5):891-897. doi: 10.1007/s00415-017-8444-9. Epub 2017 Mar 4.

PMID:
28260120
46.

Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies.

Berzero G, Hacohen Y, Komorowski L, Scharf M, Dehais C, Leclercq D, Fourchotte V, Buecher B, Honnorat J, Graus F, Delattre JY, Psimaras D.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 3;4(2):e326. doi: 10.1212/NXI.0000000000000326. eCollection 2017 Mar. No abstract available.

47.

Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model.

Ollier E, Mazzocco P, Ricard D, Kaloshi G, Idbaih A, Alentorn A, Psimaras D, Honnorat J, Delattre JY, Grenier E, Ducray F, Samson A.

Fundam Clin Pharmacol. 2017 Jun;31(3):347-358. doi: 10.1111/fcp.12259. Epub 2017 Jan 24.

PMID:
27933657
48.

SMART syndrome: Classic transient symptoms leading to an unusual unfavorable outcome.

Bompaire F, Zinchenko L, Lahutte M, Mokhtari K, Psimaras D, Gaultier C, Monjour A, Delattre JY, Ricard D.

Rev Neurol (Paris). 2017 Jan - Feb;173(1-2):67-73. doi: 10.1016/j.neurol.2016.09.014. Epub 2016 Dec 2.

PMID:
27919464
49.

[Neurosarcoidosis: Diagnosis and therapeutic issues].

Cohen Aubart F, Galanaud D, Haroche J, Psimaras D, Mathian A, Hié M, Le-Thi Huong Boutin D, Charlotte F, Maillart E, Maisonobe T, Amoura Z.

Rev Med Interne. 2017 Jun;38(6):393-401. doi: 10.1016/j.revmed.2016.10.392. Epub 2016 Nov 21. Review. French.

PMID:
27884456
50.

Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.

Bitoun S, Bouvry D, Borie R, Mahevas M, Sacre K, Haroche J, Psimaras D, Pottier C, Mathian A, Hie M, Boutin DL, Papo T, Godeau B, Valeyre D, Nunes H, Amoura Z, Cohen Aubart F.

Neurology. 2016 Dec 13;87(24):2517-2521. Epub 2016 Nov 16.

PMID:
27856779

Supplemental Content

Loading ...
Support Center